102 related articles for article (PubMed ID: 5338956)
1. Evaluation of B.663 in human leprosy.
Atkinson AJ; Sheagren JN; Rubio JB; Knight V
Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
3. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
4. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
[No Abstract] [Full Text] [Related]
5. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
6. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
7. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
[No Abstract] [Full Text] [Related]
8. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
9. G 30 320 or B 663--lampren (Geigy).
Waters MF
Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
[No Abstract] [Full Text] [Related]
10. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
11. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
12. Acute abdomen in a patient treated with lamprene.
Jagadeesan K; Visweswaran MK; Iyer KH
Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
[TBL] [Abstract][Full Text] [Related]
13. Story behind the clinical trial of B.663 in leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
[No Abstract] [Full Text] [Related]
14. B 663 (Lampren) in mycobacterial infections.
Pettit JH
Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
[No Abstract] [Full Text] [Related]
15. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease].
Languillon J
Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099
[No Abstract] [Full Text] [Related]
16. B.663 and erythema nodosum leprosum.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
[No Abstract] [Full Text] [Related]
17. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
18. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
[No Abstract] [Full Text] [Related]
19. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
20. Clofazimine in leprosy.
Browne SG
Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
